Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Sep;41(9):1629-37.
doi: 10.1007/s00134-015-3897-8. Epub 2015 Jun 13.

Electrical Pharyngeal Stimulation for Dysphagia Treatment in Tracheotomized Stroke Patients: A Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Electrical Pharyngeal Stimulation for Dysphagia Treatment in Tracheotomized Stroke Patients: A Randomized Controlled Trial

Sonja Suntrup et al. Intensive Care Med. .

Abstract

Purpose: Treatment of post-stroke dysphagia is notoriously difficult with different neurostimulation strategies having been employed with a variable degree of success. Recently, electrical pharyngeal stimulation (EPS) has been shown to improve swallowing function and in particular decrease airway aspiration in acute stroke. We performed a randomized controlled trial to assess EPS effectiveness on swallowing function in severely dysphagic tracheotomized patients.

Methods: All consecutive stroke patients successfully weaned from the respirator but with severe dysphagia precluding decannulation were screened for eligibility. Eligible patients were randomized to receive either EPS (N = 20) or sham stimulation (N = 10) over three consecutive days. Primary endpoint was ability to decannulate the patient. Swallowing function was assessed using fiberoptic endoscopy. Patients having received sham stimulation were offered EPS treatment during unblinded follow-up if required. Investigators were blinded to the patient's study group allocation.

Results: Both groups were well matched for age, stroke severity, and lesion location. Decannulation after study intervention was possible in 75% of patients of the treatment group and in 20% of patients of the sham group (p < 0.01). Secondary outcome parameters did not differ. No adverse events occurred.

Conclusion: In this pilot study, EPS enhanced remission of dysphagia as assessed with fiberoptic endoscopic evaluation of swallowing (FEES), thereby enabling decannulation in 75% of patients.

Trial registration: ClinicalTrials.gov NCT01956175.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

References

    1. Chest. 1996 Jan;109(1):167-72 - PubMed
    1. Curr Treat Options Neurol. 2014 Jan;16(1):274 - PubMed
    1. Stroke. 2005 Dec;36(12):2756-63 - PubMed
    1. Exp Transl Stroke Med. 2013 Dec 01;5(1):14 - PubMed
    1. Ann Otol Rhinol Laryngol. 2003 Oct;112(10):853-8 - PubMed

Publication types

Associated data

Feedback